Geron sells last drug in pipeline to J&J unit

November 13, 2014 11:40 PM

2 0

Geron sells last drug in pipeline to J&J unit

(Reuters) - Geron Corp licensed its cancer compound, the last in its pipeline, to a unit of Johnson & Johnson for up to $935 million, sending its shares up as much as 33 percent in extended trading.

The license deal comes as a welcome break to the company, which has seen its stock price drop from a high of $71.69 in 2000 to $2.31 on Thursday.

Also read: Hillary Clinton's Popular Vote Lead Over Donald Trump Now Exceeds 2.3 Million

Read more

To category page

Loading...